TIGERMED (Stock Code: 03347) Approves Special Resolution at 2026 EGM

Bulletin Express03-05

Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED, Stock Code: 03347) convened its 2026 First Extraordinary General Meeting (EGM) on March 5, 2026. The chairman of the board, together with all seven directors, participated in person or via video conference. Based on polling, the special resolution concerning the proposed change of registered address and corresponding amendments to the company’s Articles of Association was duly passed.

The total number of issued shares stood at 861.03 million, of which 5.88 million were treasury A Shares that abstained from voting. Consequently, 855.14 million shares were entitled to vote. Shareholders holding 431.26 million shares, representing approximately 50.43% of the total voting rights, participated in person, by proxy, or via network voting. Of those, 383.34 million shares comprised A Shares, accounting for around 44.83% of all voting shares, while 47.91 million shares were H Shares, making up about 5.60%.

In the final poll results, over two-thirds of votes were cast in favor of the special resolution. As confirmed by the scrutineers and legal advisor present, the EGM was duly convened and complied with all relevant laws, regulations, and the company’s Articles of Association. The resolution was officially approved as a special resolution of the company.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment